⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
AARD News
Aardvark Therapeutics, Inc. Common Stock
AARD Deadline: AARD Investors Have Opportunity to Lead Aardvark Therapeutics, Inc. Securities Fraud Lawsuit
prnewswire.com
AARD
AARDVARK DEADLINE: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Aardvark Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - AARD
accessnewswire.com
AARD
Securities Lawsuit Alert: Aardvark Therapeutics, Inc. (AARD) Investors - Contact Levi & Korsinsky Before October 13, 2026
accessnewswire.com
AARD
Class Action Filing Pursued by Pomerantz LLP Concerning Aardvark Therapeutics, Inc. – AARD
accessnewswire.com
AARD
Join Class Action to Recover Losses from Aardvark Therapeutics, Inc. (AARD) - Contact Levi & Korsinsky Before October 13, 2026
accessnewswire.com
AARD
October 13, 2026 Deadline Approaching: Join Class Action Against Aardvark Therapeutics, Inc. (AARD) - Contact Levi & Korsinsky
accessnewswire.com
AARD
AARDVARK DEADLINE: ROSEN, NATIONAL INVESTOR COUNSEL, Encourages Aardvark Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – AARD
globenewswire.com
AARD
Aardvark Therapeutics, Inc. (AARD) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
prnewswire.com
AARD
AARD DEADLINE NOTICE: Faruqi & Faruqi, LLP Reminds Aardvark (AARD) Investors of Securities Class Action Lawsuit Deadline on October 13, 2026
prnewswire.com
AARD
AARD STOCKHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Aardvark Therapeutics, Inc. Investors with Losses Have Opportunity to Lead Class Action Lawsuit!
accessnewswire.com
AARD